Literature DB >> 1318775

Malignant cell-specific gelatinase activity in human endometrial carcinoma.

M Takemura1, C Azuma, T Kimura, Y Tokugawa, M Miki, M Ono, F Saji, O Tanizawa.   

Abstract

BACKGROUND: The protease activity leading to degradation of the extracellular matrix was compared between human endometrial cancer and normal uterine endometrium.
METHODS: Conditioned medium from tumor cells and normal endometrial cells was subjected to electrophoresis on sodium dodecyl sulfate (SDS)-polyacrylamide gel containing gelatin as a substrate. After electrophoresis, the gel was stained with Coomassie blue, and then the enzyme activity, expressed as the zone of dye clearing, was analyzed by densitometry.
RESULTS: Densitometric analysis showed that all the endometrial cancers expressed a very high molecular weight enzyme activity (Mr 220,000), which was not detected in medium from normal endometrial cells. The analysis also showed that in endometrial cancer the activity of a Mr 92,000 enzyme was always superior to that of a Mr 64,000 enzyme, which was in contrast to the situation for normal endometrium.
CONCLUSIONS: These results indicate that the expression of Mr 220,000 enzyme activity and the higher activity of the Mr 92,000 enzyme than the Mr 64,000 enzyme are involved in the malignant phenotype of native endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318775     DOI: 10.1002/1097-0142(19920701)70:1<147::aid-cncr2820700124>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  The architecture of cancer.

Authors:  J Waxman; H Wasan
Journal:  BMJ       Date:  1992-11-28

2.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

3.  Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.

Authors:  E Miyagi; H Yasumitsu; F Hirahara; Y Nagashima; H Minaguchi; K Miyazaki; M Umeda
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

Review 4.  Physiology and pathophysiology of matrix metalloproteases.

Authors:  T Klein; R Bischoff
Journal:  Amino Acids       Date:  2010-07-18       Impact factor: 3.520

5.  Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.

Authors:  E Miyagi; H Yasumitsu; F Hirahara; H Minaguchi; N Koshikawa; K Miyazaki; M Umeda
Journal:  Jpn J Cancer Res       Date:  1995-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.